Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Tissue Banking Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Tissue Banking Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Tissue Banking Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Tissue Banking Market 36
Figure 12. Breakdown of North America Tissue Banking Market by Offering, 2019-2030, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 41
Figure 14. North America Tissue Banking Market: Equipment, 2019-2030, $ mn 42
Figure 15. North America Tissue Banking Market: Cryopreservation Equipment, 2019-2030, $ mn 44
Figure 16. North America Tissue Banking Market: Thawing Equipment, 2019-2030, $ mn 45
Figure 17. North America Tissue Banking Market: Quality Control Equipment, 2019-2030, $ mn 46
Figure 18. North America Tissue Banking Market: Labeling and Coding Equipment, 2019-2030, $ mn 47
Figure 19. North America Tissue Banking Market: Alarming and Monitoring Systems, 2019-2030, $ mn 48
Figure 20. North America Tissue Banking Market: Other Equipment, 2019-2030, $ mn 49
Figure 21. North America Tissue Banking Market: Accessories and Consumables, 2019-2030, $ mn 50
Figure 22. North America Tissue Banking Market: Services, 2019-2030, $ mn 51
Figure 23. North America Tissue Banking Market: Screening, 2019-2030, $ mn 53
Figure 24. North America Tissue Banking Market: Processing, 2019-2030, $ mn 54
Figure 25. North America Tissue Banking Market: Tissue Retrieval, 2019-2030, $ mn 55
Figure 26. North America Tissue Banking Market: Testing, 2019-2030, $ mn 56
Figure 27. North America Tissue Banking Market: Storage and Preservation, 2019-2030, $ mn 57
Figure 28. North America Tissue Banking Market: Other Services, 2019-2030, $ mn 58
Figure 29. Breakdown of North America Tissue Banking Market by Application, 2019-2030, % of Sales Revenue 60
Figure 30. North America Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 60
Figure 31. North America Tissue Banking Market: Therapeutics, 2019-2030, $ mn 61
Figure 32. North America Tissue Banking Market: Medical Research, 2019-2030, $ mn 62
Figure 33. North America Tissue Banking Market: Cosmetics, 2019-2030, $ mn 63
Figure 34. North America Tissue Banking Market: Other Applications, 2019-2030, $ mn 64
Figure 35. Breakdown of North America Tissue Banking Market by Tissue Type, 2019-2030, % of Sales Revenue 66
Figure 36. North America Addressable Market Cap in 2021-2030 by Tissue Type, Value ($ mn) and Share (%) 66
Figure 37. North America Tissue Banking Market: Cardiovascular Tissue, 2019-2030, $ mn 67
Figure 38. North America Tissue Banking Market: Corneal Tissue, 2019-2030, $ mn 68
Figure 39. North America Tissue Banking Market: Lungs Tissue, 2019-2030, $ mn 69
Figure 40. North America Tissue Banking Market: Kidney Tissue, 2019-2030, $ mn 70
Figure 41. North America Tissue Banking Market: Bone Tissue, 2019-2030, $ mn 71
Figure 42. North America Tissue Banking Market: Skin Tissue, 2019-2030, $ mn 72
Figure 43. North America Tissue Banking Market: Brain & Spinal Cord, 2019-2030, $ mn 73
Figure 44. North America Tissue Banking Market: Others Tissue Types, 2019-2030, $ mn 74
Figure 45. Breakdown of North America Tissue Banking Market by End User, 2019-2030, % of Revenue 76
Figure 46. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 76
Figure 47. North America Tissue Banking Market: Biobanks, 2019-2030, $ mn 77
Figure 48. North America Tissue Banking Market: Hospitals and Clinics, 2019-2030, $ mn 78
Figure 49. North America Tissue Banking Market: Research and Academic Institutes, 2019-2030, $ mn 79
Figure 50. North America Tissue Banking Market: Other End Users, 2019-2030, $ mn 80
Figure 51. Breakdown of North America Tissue Banking Market by Country, 2019 and 2030F, % of Revenue 82
Figure 52. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 83
Figure 53. U.S. Tissue Banking Market, 2019-2030, $ mn 85
Figure 54. Canada Tissue Banking Market, 2019-2030, $ mn 87
Figure 55. Tissue Banking Market in Mexico, 2015-2030F, $ mn 89
Figure 56. Growth Stage of North America Tissue Banking Industry over the Forecast Period 91
North America tissue banking market is expected to grow by 8.5% annually in the forecast period and reach $17.82 billion by 2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry. Highlighted with 24 tables and 56 figures, this 111-page report “North America Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Equipment o Cryopreservation Equipment o Thawing Equipment o Quality Control Equipment o Labeling and Coding Equipment o Alarming and Monitoring Systems o Other Equipment • Accessories and Consumables • Services o Screening o Processing o Tissue Retrieval o Testing o Storage and Preservation o Other Services Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Therapeutics • Medical Research • Cosmetics • Other Applications Based on Tissue Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Cardiovascular Tissue • Corneal Tissue • Lungs Tissue • Kidney Tissue • Bone Tissue • Skin Tissue • Brain & Spinal Cord • Others Tissue Types Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Biobanks • Hospitals and Clinics • Research and Academic Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Offering, Application, and Tissue Type over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): AMS Biotechnology Ltd. Avantor Inc. (VWR International) Beckman Coulter, Inc. Bio-Rad Laboratories Inc. Bluechiip Limited Brooks Lifesciences (Brooks Automation Inc.) Custom Biogenic Systems, Inc. Eppendorf AG Hamilton Company Merck KGaA Organ Recovery Systems, Inc. PHC Holdings Corporation Sartorius AG Taylor-Wharton International LLC Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More